Lördag 13 September | 07:13:38 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-02-25 08:00 Bokslutskommuniké 2025
2025-11-19 09:20 Kvartalsrapport 2025-Q3
2025-08-29 - Kvartalsrapport 2025-Q2
2025-05-30 - X-dag ordinarie utdelning ZZ B 4.00 SEK
2025-05-28 - Årsstämma
2025-05-20 - Kvartalsrapport 2025-Q1
2025-02-27 - Bokslutskommuniké 2024
2024-11-19 - Kvartalsrapport 2024-Q3
2024-08-30 - Kvartalsrapport 2024-Q2
2024-05-28 - X-dag ordinarie utdelning ZZ B 3.00 SEK
2024-05-27 - Årsstämma
2024-05-22 - Kvartalsrapport 2024-Q1
2024-02-27 - Bokslutskommuniké 2023
2023-11-16 - Kvartalsrapport 2023-Q3
2023-08-31 - Kvartalsrapport 2023-Q2
2023-06-01 - X-dag ordinarie utdelning ZZ B 1.75 SEK
2023-05-31 - Årsstämma
2023-05-12 - Kvartalsrapport 2023-Q1
2023-02-28 - Bokslutskommuniké 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-08-26 - Kvartalsrapport 2022-Q2
2022-06-01 - X-dag ordinarie utdelning ZZ B 2.00 SEK
2022-05-31 - Årsstämma
2022-05-13 - Kvartalsrapport 2022-Q1
2022-02-28 - Bokslutskommuniké 2021
2021-11-19 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning ZZ B 1.00 SEK
2021-05-21 - X-dag bonusutdelning ZZ B 0.25
2021-05-20 - Årsstämma
2021-05-18 - Kvartalsrapport 2021-Q1
2021-02-26 - Bokslutskommuniké 2020
2020-11-20 - Kvartalsrapport 2020-Q3
2020-08-28 - Kvartalsrapport 2020-Q2
2020-05-18 - X-dag bonusutdelning ZZ B 0.15
2020-05-18 - X-dag ordinarie utdelning ZZ B 0.55 SEK
2020-05-15 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-28 - Bokslutskommuniké 2019
2019-11-15 - Kvartalsrapport 2019-Q3
2019-08-30 - Kvartalsrapport 2019-Q2
2019-05-23 - X-dag bonusutdelning ZZ B 0.2
2019-05-23 - X-dag ordinarie utdelning ZZ B 0.50 SEK
2019-05-22 - Årsstämma
2019-05-16 - Kvartalsrapport 2019-Q1
2019-02-28 - Bokslutskommuniké 2018
2018-11-15 - Kvartalsrapport 2018-Q3
2018-08-30 - Kvartalsrapport 2018-Q2
2018-05-16 - X-dag ordinarie utdelning ZZ B 0.45 SEK
2018-05-15 - Årsstämma
2018-05-15 - Kvartalsrapport 2018-Q1
2018-02-28 - Bokslutskommuniké 2017
2017-11-13 - Kvartalsrapport 2017-Q3
2017-08-31 - Kvartalsrapport 2017-Q2
2017-05-26 - X-dag ordinarie utdelning ZZ B 0.25 SEK
2017-05-24 - Årsstämma
2017-05-10 - Kvartalsrapport 2017-Q1
2017-02-28 - Bokslutskommuniké 2016
2016-11-15 - Kvartalsrapport 2016-Q3
2016-08-31 - Kvartalsrapport 2016-Q2
2016-05-23 - X-dag ordinarie utdelning ZZ B 0.25 SEK
2016-05-20 - Årsstämma
2016-05-20 - Kvartalsrapport 2016-Q1
2016-02-29 - Bokslutskommuniké 2015
2015-11-23 - Kvartalsrapport 2015-Q3
2015-08-31 - Kvartalsrapport 2015-Q2
2015-05-22 - Kvartalsrapport 2015-Q1
2015-05-06 - X-dag ordinarie utdelning ZZ B 0.25 SEK
2015-05-05 - Årsstämma
2015-02-27 - Bokslutskommuniké 2014
2014-11-14 - Kvartalsrapport 2014-Q3
2014-08-29 - Kvartalsrapport 2014-Q2
2014-05-19 - X-dag ordinarie utdelning ZZ B 0.10 SEK
2014-05-16 - Årsstämma
2014-04-25 - Kvartalsrapport 2014-Q1
2014-02-26 - Bokslutskommuniké 2013
2013-10-25 - Kvartalsrapport 2013-Q3
2013-08-31 - Kvartalsrapport 2013-Q2
2013-06-13 - X-dag ordinarie utdelning ZZ B 0.00 SEK
2013-06-12 - Årsstämma
2013-04-25 - Kvartalsrapport 2013-Q1
2013-02-28 - Bokslutskommuniké 2012
2012-10-25 - Kvartalsrapport 2012-Q3
2012-08-31 - Kvartalsrapport 2012-Q2
2012-05-14 - Kvartalsrapport 2012-Q1
2012-05-08 - Årsstämma
2012-02-28 - Bokslutskommuniké 2011
2011-11-15 - Kvartalsrapport 2011-Q3
2011-11-14 - Extra Bolagsstämma 2011
2011-08-31 - Kvartalsrapport 2011-Q2
2011-05-12 - Kvartalsrapport 2011-Q1
2011-05-10 - X-dag ordinarie utdelning ZZ B 0.00 SEK
2011-05-09 - Årsstämma
2011-02-28 - Bokslutskommuniké 2010

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHandel & varor
IndustriDetaljhandel
Zinzino är verksamt inom hälsovård och kosttillskott. Bolaget marknadsför och säljer produkter som berör en stor del områden som hudvård, immunsystem och viktnedsättning. Exempel på produkter som bolaget säljer inkluderar omega 3 olja, måltidsersättningar och kaffe. Zinzino innehar idag främst verksamhet inom Norden, Europa och Nordamerika. Huvudkontoret ligger i Västra Frölunda.
2025-09-12 16:30:00

Zinzino has today acquired the rights to the distributor database and associated customer register, inventory, and IP rights of US-based direct sales company Bodē Pro through an asset acquisition. This is another strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.

Bodē Pro is a global direct sales company in the health segment, operating primarily in North America and Japan. Its brand portfolio offers a range of innovative products in the health and wellness sector.
 

The business has a total annual turnover of approximately USD 7 million. The collaboration with Zinzino is expected to add growth through the synergies that arise in the joint networks, combined with Zinzino's test-based product concept and Bodē Pro's innovative product range. Profitability through the transactions will thus be able to develop well by utilizing Zinzino's existing technical platform and organization.

The partnership will also accelerate Zinzino's expansion in Japan, one of the most sought-after markets in the direct sales industry. Approximately 55% of Bodē Pro's total revenue currently comes from the Japanese market.

According to the asset purchase agreement, Zinzino will pay a fixed purchase price of USD 2 million upon completion, of which 50% will be settled through newly issued Zinzino shares. In addition, there will be a deferred purchase price of USD 0.4 million and additional purchase prices based on future sales development, which at maximum outcome may amount to USD 3.6 million. The additional purchase price shall be settled in full with newly issued Zinzino shares. The cash portion of the purchase price shall be paid from the company's own cash reserves.

A visionary mindset, tech-first perspective, test-based nutrition at the cellular level, and a strong position to capitalize on current trends will form the basis of the partnership with Ecosystem. Following the acquisitions of VMA Life in 2020, Enhanzz in 2022, Xelliss and ACN in 2024, and the asset acquisitions of Zurvita, Valentus, and Ecosystem in 2025, Zinzino has been looking for additional investments to maintain its sustainable, profitable growth, strengthen its distribution power, expand into new markets, and leverage its product portfolio in new consumer areas.

"Individualized advice and tailored solutions are the future, and not just in health and wellness," says Dag Bergheim Pettersen, CEO of Zinzino. Together with BK Boreyko, CEO and founder of Bodē Pro, we have many years of combined industry experience and everything it takes to drive the modern, personalized shopping experience through direct sales.

Bodē Pro's clinically studied product formulations will now integrate into the Zinzino portfolio. "Every great leader's responsibility is to place their team in the best environment for growth and success. In my 25 years as a CEO, in today's marketplace, there's not a better opportunity than Zinzino to accomplish that!' says Boreyko.  "I started in this industry as a field leader and I'm excited to get back to that since it's what I love the most about this industry."

For more information, please contact:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Images for free publication:
marketing@zinzino.com
 

Certified Adviser:
DNB Carnegie Investment Bank AB (publ.)